Sildenafil Studied in Women With Antidepressant-Associated Sexual Dysfunction

Sildenafil is a standard

Are there pills or other medications that increase sex drive in women?

Viagra is FDA approved to treat erectile dysfunction. It doesn’t have approval for treating female sexual dysfunction, and studies thus far have had mixed results. There’s no “female Viagra,” but there are a couple of drugs with approval to treat sexual dysfunction associated with specific conditions. There are many reasons for low sex drive. Before taking Viagra or any other medication, talk with your doctor about the potential benefits, risks, and side effects of these medications for you.

Ospemifene (Osphena)

While some side effects such as nausea, dizziness, and headaches associated with selective serotonin reuptake inhibitor (SSRI) antidepressants tend to decrease or resolve over time, other side effects such as sexual dysfunction rarely remit spontaneously. Treatment of sexual side effects in women is especially important when about 30-70% of patients taking antidepressants may experience sexual side effects, combined with the fact that women are prescribed antidepressants at rates of 2 to 1 when compared to men. Sexual side effects in women may entail decreased sexual desire, difficulty with orgasm, genital sensitivity, reduced sexual activity, pain with sexual intercourse, decreased vaginal lubrication, and dissatisfaction or loss of pleasure from sexual activity. Sildenafil, marketed under the name Viagra, is a selective phosphodiesterase type 5 inhibitor approved for the treatment of erectile dysfunction in men, and has received study for men with depression and erectile dysfunction associated with SSRI treatment. In women, initial trials using selective phosphodiesterase inhibitors looking at both premenopausal and postmenopausal women did not show significant improvements for sexual arousal disorder; however, later randomized controlled trials supported their use for the improved frequency of sexual intercourse, arousal, orgasm, and satisfaction. treatment for male erectile dysfunction,

• Sildenafil works by relaxing blood vessels, increasing blood flow to genital areas.
• Female sexual arousal disorder may potentially be treated with sildenafil.
• Research shows mixed results regarding sildenafil's effectiveness in women.
• Sildenafil is not approved by the FDA specifically for women’s sexual problems.
• Possible risks for women include headaches and low blood pressure.
• Always consult a healthcare provider before trying sildenafil for women.

but its application in

Side Effect	Severity	Frequency	Management Tips
Headache	Mild to moderate	Frequent	Hydration, pain relievers
Flushing	Mild	Common	Cooling measures
Nasal Congestion	Mild	Occasional	Decongestants
Dizziness	Mild	Less common	Sitting or lying down
Visual Disturbances	Rare	Rare	Seek medical attention

female sexual dysfunction remains uncertain.

• Sildenafil is often known by the brand name Viagra, primarily for men.
• Researchers are exploring other PDE5 inhibitors for women’s sexual health.
• Efficacy of sildenafil in women might depend on underlying health conditions.
• Women with cardiovascular issues should be particularly cautious with sildenafil.
• Some women report increased sexual satisfaction after using sildenafil.
• Medical advice is crucial before women consider sildenafil as a treatment.

These Italian authors conducted

• Sildenafil may help women with conditions like arousal disorder, but evidence varies.
• There is ongoing research into safe, effective female-specific doses of sildenafil.
• Side effects experienced by women can include dizziness, nausea, or visual disturbances.
• Consumption of alcohol while on sildenafil can increase side effect risks.
• Female sexual dysfunction can have psychological, hormonal, and physical causes.
• Sildenafil is not a cure-all; proper diagnosis is important for targeted treatment.

a randomized, double-blind, .. These Italian authors conducted

Product	Dosage	Quantity + Bonus	Price
Kamagra Polo	100mg	180 + 8 Pills	446.52€ 425.26€	Buy
Kamagra Oral Jelly	100mg	220 + 18 Sachets	662.24€ 630.70€	Buy
Kamagra Polo	100mg	272 + 12 Pills	622.94€ 593.28€	Buy
Viagra Generic	200mg	10 Pills	40.96€ 39.01€	Buy
Kamagra Soft Tabs	100mg	32 Pills	120.11€ 114.39€	Buy
Viagra Generic	25mg	20 Pills	37.74€ 35.94€	Buy
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€	Buy
Kamagra Oral Jelly	100mg	63 + 7 Sachets	224.18€ 213.50€	Buy
Kamagra Polo	100mg	20 Pills	83.56€ 79.58€	Buy
Viagra Generic	25mg	60 + 4 Pills	71.99€ 68.56€	Buy
Kamagra Oral Jelly	100mg	10 Sachets	54.55€ 51.95€	Buy
Viagra Generic	50mg	360 + 10 Pills	225.33€ 214.60€	Buy
Viagra Generic	50mg	180 + 8 Pills	158.82€ 151.26€	Buy
Viagra Generic	200mg	30 + 2 Pills	83.07€ 79.11€	Buy

a randomized, double-blind, crossover

Interested, but not quite ready?

DARE to PLAY is a topical sildenafil cream enhancing female arousal, available in select states as a compounded product while awaiting FDA approval. Clinical trials showed improved arousal sensation scores, though not statistically significant compared to placebo, with significant benefits in a subset of women with FSAD. Daré Bioscience said the sildenafil cream’s availability will expand to other states throughout December 2025 and early 2026. DARE to PLAY, a proprietary topical arousal cream designed to enhance genital blood flow and arousal response in women, can now be prescribed in select states, manufacturer Daré Bioscience, Inc announced in a news release.1 “When Viagra [sildenafil citrate] was approved in 1998, it revolutionized sexual medicine for men. But for women, comparable progress on enhancing the natural arousal sensations has stalled for nearly 3 decades,” said Sabrina Martucci Johnson, President and CEO of Daré Bioscience, in sildenafil citrate tablets for female the news release.

Setting and Sample

“We believe DARE to PLAY represents a long overdue correction, giving women an option to reconnect with their own bodies, their pleasure, and their confidence, using science that finally recognizes their needs.”1 As the company continues the process to seek FDA approval of the sildenafil cream formulation, it is making the cream available in the form of a Section 503B compounded product. Although the sildenafil cream is manufactured “in an outsourcing facility subject to FDA inspection and under current Good Manufacturing Practice regulations,” Daré Bioscience noted that compounded drugs are not FDA approved or evaluated by the agency for “safety, effectiveness, or quality.”1 DARE to PLAY is currently available for prescription for pre-order in Connecticut, Florida, Indiana, Missouri, New Jersey, Oregon, Pennsylvania, Rhode Island, and Utah. Daré Bioscience said the sildenafil cream’s availability will expand to other states throughout December 2025 and early 2026.1 DARE to PLAY has been evaluated in several studies, including a phase 2b randomized controlled trial (NCT04948151), the results of which were published in Obstetrics & Gynecology. In that study, 200 women with female sexual arousal disorder (FSAD) were randomly assigned to receive the sildenafil cream or placebo cream. The co-primary efficacy end points included change from baseline to week 12 in the Arousal Sensation domain of the Sexual Function Questionnaire (SFQ28), as well as question 14 of the Female Sexual Distress Scale—Desire, Arousal, Orgasm (FSDS-DAO).2 Greater improvement in SFQ28 Arousal Sensation domain scores was observed in patients receiving sildenafil cream, although “there were no statistically significant differences between sildenafil and placebo cream users in the coprimary and secondary efficacy end points,” wrote the authors. study to explore the use of sildenafil in

Ready to see why DARE to PLAY could be the best you've ever had?

But these are different drugs with different missions. Addyi is a brand name for a nonhormonal medication called flibanserin. You inject it under the skin on your abdomen or thigh about 45 minutes before you plan to have sex. Both medications are approved to treat acquired, generalized sexual desire disorder in premenopausal women. Specifically, it’s for low sexual desire that causes distress, but is unrelated to: Addyi and Vyleesi treat sexual desire, though the exact mechanism of action isn’t clear.

Competing interests

They seem to affect certain pathways in the brain that influence sexual desire. Side effects of Addyi sildenafil citrate tablets 50mg include low blood pressure, fainting, and nausea. These effects may be more intense if you take birth control pills or drink alcohol. Side effects of Vyleesi include a temporary increase in blood pressure and a decrease in heart rate. It can also cause nausea and isolated spots of skin lightening (focal hyperpigmentation). 51 women (aged 22-38) with documented ovarian function

Society and culture

conducted over 7 outpatient medical centers, 98 premenopausal women with remitted depression on SSRI antidepressants, ages 18-50 years old, were enrolled into an 8 week prospective, parallel- group, randomized, double blind, placebo controlled clinical trial. This study used the Clinical Global Impression sexual function scale as a primary measure, and also utilized the Female Sexual Function Questionnaire, the Arizona Sexual Experience Scale-female version, and the University of New Mexico Sexual Function Inventory- female version, a sexual activity event log, and the Hamilton Depression Rating Scale. This study showed that doses of sildenafil between 50mg-100mg, with the mean study dose of 91.7 mg, lead to an improvements in sexual side effects in the treatment group compared to the placebo control group. 28% of women taking sildenafil reported no improvement with the treatment, while 73% of women taking placebo reported no improvement. There was no statistical difference in the baseline and end-of-study Hamilton depression scores.

Addyi (Flibanserin)

While there were no baseline endocrine value differences between the two groups, participants with higher levels of testosterone and thyroxin were more likely to experience improvement in sexual function, regardless of the assigned treatment group. Headache, flushing, dyspepsia, nasal congestion, and transient visual disturbances were the most common adverse events reported with sildenafil use in this study; nausea and increased anxiety were more commonly reported in the placebo group than the study group. This is the first randomized placebo-controlled study to show a significant decrease in sexual side effects when looking at the use of sildenafil in premenopausal women with SSRI-associated sexual dysfunction, supporting previous case reports and open label studies of this medication in this population. Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil Treatment of Women with Antidepressant-Associated Sexual Dysfunction. who reported adequate sexual

Are there other uses for this medicine?

The product label doesn’t include dosing information for FSAD because it’s not the intended use. In studies, doses for female use may vary significantly. If you do plan on taking Viagra, consider the source. Some online sites that claim to sell Viagra are selling counterfeit drugs. These may not work like Viagra and may not be safe.

Exclusion Criteria

To access the real thing, you’ll need a prescription. A doctor will decide on the dose and provide safety information. Viagra is an ED medication that improves blood flow to the penis. Viagra is a brand name, and there’s no “Viagra for women.” There are, however, a few FDA-approved medications to treat low female sexual desire. Because it’s a pink tablet and Viagra is a blue tablet, the nickname “female Viagra” was bound to happen. desire but decreased arousal.

Why trust our experts?

The investigators also conducted an exploratory post hoc analysis evaluating a subset of the intention-to-treat population who had a diagnosis of FSDD with or without concomitant decreased desire. In this subset, significant increases in SFQ28 Arousal Sensation domain score were seen vs the placebo group. These patients also had a higher mean improvement in SFQ28 Desire and Orgasm domain scores, as well as significantly decreased sexual distress and interpersonal difficulties as assessed by FSDS-DAO questions 3, 5, and 10.2 “As more women speak openly about their sexual health, the need for research-backed solutions has never been greater,” said Irwin Goldstein, MD, director of San Diego Sexual Medicine in California and a founder of the International Society for the Study of Women’s Sexual Health in the news release. “Daré’s commitment to both clinical integrity and timely access ensures women who need it don’t have to wait to benefit from this innovation.”1 DARE to PLAY sildenafil cream now available for pre-order by prescription: First evidence-based topical arousal cream for women begins commercial rollout in select states via 503B outsourcing facility. Preliminary efficacy of topical sildenafil cream for the treatment of female sexual arousal disorder: A randomized controlled trial.